Trump to visit Fed on Thursday amid Powell feud, renovation probe
LONDON - Investment management firm BlackRock (NYSE:BLK), Inc. has reduced its stake in CVS Group plc to below 5%, according to a regulatory filing published Wednesday.
The notification, submitted to the Financial Conduct Authority, indicates that BlackRock crossed below the reportable threshold on June 30, 2025. The company notified CVS Group of the change on July 1.
Prior to this reduction, BlackRock held 5.02% of voting rights in the veterinary services provider, consisting of 4.31% in shares and 0.70% through financial instruments. The current holdings now fall below the 5% disclosure threshold that requires public notification under UK transparency rules.
The filing shows that BlackRock’s interest in CVS Group includes direct shareholdings as well as positions through financial instruments such as securities lending arrangements and contracts for difference (CFDs).
BlackRock manages its investment in CVS Group through multiple controlled entities in its corporate structure, including BlackRock Financial Management, BlackRock Investment Management (UK) Limited, and several other subsidiaries across multiple jurisdictions.
The standard regulatory disclosure, known as a TR-1 form, was completed in London on July 1, 2025, by BlackRock’s Regulatory Threshold Reporting Team.
This information was released through a Regulatory News Service announcement by CVS Group plc, based on the company’s press release statement.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.